chr12-101757566-A-C

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4

The NM_024312.5(GNPTAB):​c.3335+6T>G variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,343,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

GNPTAB
NM_024312.5 splice_donor_region, intron

Scores

2
Splicing: ADA: 0.0002851
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8O:1

Conservation

PhyloP100: 1.61
Variant links:
Genes affected
GNPTAB (HGNC:29670): (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-101757566-A-C is Pathogenic according to our data. Variant chr12-101757566-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 2773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-101757566-A-C is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GNPTABNM_024312.5 linkuse as main transcriptc.3335+6T>G splice_donor_region_variant, intron_variant ENST00000299314.12 NP_077288.2
GNPTABXM_006719593.4 linkuse as main transcriptc.3335+6T>G splice_donor_region_variant, intron_variant XP_006719656.1
GNPTABXM_011538731.3 linkuse as main transcriptc.3254+6T>G splice_donor_region_variant, intron_variant XP_011537033.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GNPTABENST00000299314.12 linkuse as main transcriptc.3335+6T>G splice_donor_region_variant, intron_variant 1 NM_024312.5 ENSP00000299314 P1Q3T906-1
GNPTABENST00000550718.1 linkuse as main transcriptc.147+6T>G splice_donor_region_variant, intron_variant 3 ENSP00000449557
GNPTABENST00000549738.5 linkuse as main transcriptc.86+6T>G splice_donor_region_variant, intron_variant, NMD_transcript_variant 4 ENSP00000450161
GNPTABENST00000549194.1 linkuse as main transcriptn.201+6T>G splice_donor_region_variant, intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000461
AC:
7
AN:
151864
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000478
AC:
12
AN:
251120
Hom.:
0
AF XY:
0.0000589
AC XY:
8
AN XY:
135772
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000117
AC:
140
AN:
1191500
Hom.:
0
Cov.:
18
AF XY:
0.000120
AC XY:
73
AN XY:
606416
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000154
Gnomad4 OTH exome
AF:
0.000136
GnomAD4 genome
AF:
0.0000461
AC:
7
AN:
151864
Hom.:
0
Cov.:
32
AF XY:
0.0000674
AC XY:
5
AN XY:
74220
show subpopulations
Gnomad4 AFR
AF:
0.0000243
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000867
Hom.:
0
Bravo
AF:
0.0000567
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMar 25, 2022- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 04, 2024This sequence change falls in intron 17 of the GNPTAB gene. It does not directly change the encoded amino acid sequence of the GNPTAB protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs34788341, gnomAD 0.01%). This variant has been observed in individual(s) with mucolipdosis III alpha/beta (PMID: 16465621, 19617216). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS17+6T>G. ClinVar contains an entry for this variant (Variation ID: 2773). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 17 and introduces a premature termination codon (PMID: 16465621). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingCounsylJan 11, 2017- -
Mucolipidosis type II Pathogenic:2Other:1
not provided, no classification providedliterature onlyGeneReviews-- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Pathogenic, criteria provided, single submitterclinical testingBaylor Genetics-- -
Pseudo-Hurler polydystrophy Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMMar 01, 2006- -
Mucopolysaccharidosis, MPS-III-A Pathogenic:1
Pathogenic, no assertion criteria providedcurationGeneReviewsMay 10, 2012- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityOct 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.5
DANN
Benign
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00029
dbscSNV1_RF
Benign
0.11
SpliceAI score (max)
0.54
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.54
Position offset: 6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34788341; hg19: chr12-102151344; API